Oral choline supplementation for postoperative pain

Area of Science:

• Anesthesiology
• Pharmacology
• Pain Management

Background:

• Nicotinic receptor activation, including by nicotine, shows potential for reducing post-surgical pain.
• Choline, a selective α7-nicotinic receptor agonist, exhibits anti-nociceptive properties in preclinical models without addictive or sympathetic effects.
• Lecithin was investigated for oral choline supplementation to manage post-gynecological surgery pain.

Purpose of the Study:

• To evaluate the efficacy of oral choline supplementation via lecithin in managing pain after gynecological surgery.
• To assess the impact of choline supplementation on plasma choline concentrations and tumor necrosis factor (TNF) levels.
• To determine if choline supplementation offers an alternative pain management strategy with a favorable safety profile.

Main Methods:

• A double-blind, randomized trial involving sixty women undergoing open gynecological surgery.
• Participants received either 20g of lecithin or a placebo before surgery.
• Measurements included plasma choline concentration, tumor necrosis factor (TNF), and pain reports (primary outcome).

Main Results:

• Oral lecithin supplementation resulted in a statistically significant but small increase in plasma choline levels post-surgery.
• No significant reduction in plasma TNF levels was observed between the lecithin and placebo groups.
• Pain reports at rest and during movement did not differ significantly between the groups, and no adverse effects were noted.

Conclusions:

• Perioperative oral lecithin supplementation led to slow absorption, achieving insufficient plasma choline concentrations for anti-inflammatory or analgesic effects.
• The inability to adequately increase plasma choline concentrations likely explains the lack of TNF reduction and pain relief.
• The study suggests that current oral lecithin supplementation protocols may not be effective for managing post-surgical pain and inflammation.